This inventor holds 1 USPTO granted patent. Top assignee: Takeda Gmbh. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Mahindra Makhija: Innovator in EP2 Receptor Agonists
Introduction
Mahindra Makhija is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmacology, particularly in the development of EP2 receptor agonists. His work has the potential to impact various therapeutic areas.
Latest Patents
Makhija holds a patent for EP2 receptor agonists, specifically for compounds of formula (1) where R1, R4, A, and X have specific meanings as described in the patent documentation. This innovation is recognized as a novel and effective approach to targeting EP2 receptors.
Career Highlights
He is currently employed at Takeda GmbH, a global pharmaceutical company known for its commitment to research and development. His role at Takeda allows him to further his research and contribute to the advancement of medical science.
Collaborations
Makhija has worked alongside esteemed colleagues such as Angelika Hoffmeyer and Rainer Boer. Their collaborative efforts have fostered an environment of innovation and discovery within their field.
Conclusion
Mahindra Makhija's contributions to the development of EP2 receptor agonists highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for advancements in therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile